A Unified Strategy for the Enantioselective Synthesis of All Conduritol Stereoisomers via Enzymatic Resolution and Stereospecific Transformation
Overview
This article is based on the groundbreaking work by Kwon and Chung, published in Organic Letters. It details a universal strategy for synthesizing all Conduritol stereoisomers through enzymatic resolution and stereospecific transformations, providing an efficient and versatile solution for accessing these important cyclohexenetetrol compounds.
Main Content
1. Background
Conduritols are crucial building blocks in organic synthesis and important scaffolds for drug discovery. Among the six stereoisomers (A–F), A and D are meso compounds, while B, C, E, and F exist as enantiomeric pairs. Their derivatives exhibit various biological activities, including glycosidase inhibition, antiviral effects, and insulin modulation, making them valuable targets in pharmaceutical research and chemical biology.
2. Core Strategy
The study employs a two-step strategy to achieve the complete synthesis of all isomers:
Step 1: Enzymatic Kinetic Resolution
Step 2: Stereodivergent Synthesis
All isomers are constructed via three classic reaction strategies:
Target Compound
Key Reactions
Stereochemical Control
Conduritol D
Swern oxidation → NaBH₄ reduction
Stereoselective reduction
Conduritol A
Mitsunobu reaction
Configuration inversion
Conduritol E/F
Regioselective benzoylation → Mitsunobu reaction
Regio- and stereocontrol
3. Key Advantages
✔ Comprehensive
✔ High Selectivity
✔ Practicality
✔ Derivatization Potential
4. Research Impact
Drug Discovery
Chemical Biology
Organic Synthesis
5. Conclusion
This research addresses the long-standing synthetic challenge of accessing all Conduritol stereoisomers through a combined enzymatic resolution and stereospecific transformation strategy. The method not only holds significant value for synthetic chemistry but also provides essential molecular tools for drug discovery and chemical biology research based on this scaffold. As our understanding of glycosidase-related disease mechanisms deepens, the application prospects for these compounds will continue to expand.


